What is the recommended treatment for an adult with suspected pertussis?

Treatment of Pertussis in Adults

For adults with suspected pertussis, treat with azithromycin 500 mg on day 1, followed by 250 mg daily on days 2-5. This is the preferred first-line antibiotic based on CDC guidelines, offering superior tolerability and compliance compared to older regimens 1.

Antibiotic Options and Dosing

First-Line: Azithromycin (Preferred)

• Dosing: 500 mg on day 1, then 250 mg daily for days 2-5 (total 5 days) 1
• Advantages:
  • Shorter course improves compliance
  • Fewer gastrointestinal side effects compared to erythromycin
  • Once-daily dosing
  • Fewer drug interactions than erythromycin or clarithromycin 1
• Cautions: Avoid concurrent aluminum/magnesium antacids; use cautiously with impaired hepatic function 1

Alternative: Clarithromycin

• Dosing: 1 g per day in two divided doses for 7 days 1
• Note: Similar efficacy to azithromycin but requires twice-daily dosing for 7 days

Alternative: Erythromycin

• Dosing: 2 g per day in 4 divided doses for 14 days 1
• Limitations:
  • Requires 14-day course (relapses reported with shorter courses)
  • Significant gastrointestinal side effects (dose-related)
  • Multiple drug interactions via CYP3A inhibition
  • Poor compliance due to side effects and dosing frequency 1

Alternative for Macrolide Allergy: TMP-SMZ

• For patients who cannot tolerate macrolides 1
• Emerging concern: Recent reports from China describe macrolide-resistant Bordetella pertussis strains, where TMP-SMZ may be necessary 2, 3, 4

Critical Clinical Considerations

Timing of Treatment

Antibiotics do NOT improve symptoms or shorten disease duration if started after the catarrhal stage 1, 5, 6. The primary purpose of treatment in adults is to:

• Eradicate nasopharyngeal carriage of B. pertussis
• Reduce transmission to vulnerable populations (especially infants)
• Render the patient non-infectious within 5 days of starting treatment 1, 5

When to Treat

• Confirmed or suspected pertussis with cough <3 weeks duration
• Close contacts of confirmed cases who are high-risk or have contact with high-risk individuals (prophylaxis uses same dosing) 1
• Adults are often the reservoir infecting vulnerable infants, making treatment epidemiologically important even when symptoms are mild 1, 7

Diagnostic Confirmation

Before treating, confirm diagnosis when possible:

• PCR testing is now preferred over culture (faster, more sensitive) 7, 6
• Culture and PCR most useful when cough <3 weeks duration
• Serology not routinely recommended or standardized 6

Important Pitfalls to Avoid

1. Don't delay treatment waiting for confirmation if clinical suspicion is high and patient has contact with vulnerable populations
2. Don't expect symptom improvement from antibiotics—counsel patients that treatment prevents transmission, not symptom relief 5, 6
3. Don't use erythromycin as first-line given poor tolerability and compliance issues 1, 5
4. Don't forget isolation precautions: Respiratory isolation for 5 days after starting effective antibiotics 1
5. Consider macrolide resistance if patient fails to improve clinically and has epidemiologic risk factors (recent travel to areas with known resistance) 2, 3, 4

Drug Interactions and Contraindications

• Contraindicated: History of hypersensitivity to macrolides 1
• Erythromycin/clarithromycin: Do not use with astemizole, cisapride, pimozide, or terfenadine (risk of cardiac arrhythmias) 1
• Azithromycin: Fewer CYP450 interactions than other macrolides, but monitor when used with digoxin, triazolam, or ergot alkaloids 1

Pregnancy Considerations

• Azithromycin: FDA Pregnancy Category B (preferred in pregnancy) 1
• Erythromycin: FDA Pregnancy Category B 1
• Clarithromycin: FDA Pregnancy Category C (avoid if possible) 1